APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,568	2,049	1,642	1,204	822.86
Other Revenue	16.41	16.62	8.49	11.55	5.82
Revenue	2,584	2,066	1,650	1,216	828.69
Revenue Growth (YoY)	25.08%	25.18%	35.71%	46.74%	72.85%
Cost of Revenue	707.39	579.89	486.14	354.04	259.08
Gross Profit	1,877	1,486	1,164	861.98	569.61
Selling, General & Admin	579.25	464.34	386.96	307.57	251.43
Research & Development	364.8	290.54	237.92	174.88	134.88
Other Operating Expenses	28.18	15.22	14.52	13.75	8.14
Operating Expenses	988.53	772.32	639.21	496.99	393.93
Operating Income	888.01	713.59	524.86	364.99	175.68
Interest Expense	-1.46	-2.01	-3.69	-1.45	-1.63
Interest & Investment Income	30.73	25.23	27.74	23.94	13.26
Currency Exchange Gain (Loss)	-5.3	2.83	2.66	1.17	-1
Other Non Operating Income (Expenses)	-0.83	-0.82	-0.04	-0.49	-0.5
EBT Excluding Unusual Items	911.16	738.83	551.53	388.16	185.81
Impairment of Goodwill	-	-	-3.84	-	-
Gain (Loss) on Sale of Investments	0.49	-16.7	-	0.34	21.72
Gain (Loss) on Sale of Assets	-0.93	0.25	11.97	0.06	0.02
Asset Writedown	-1.85	-0.83	-0.12	-10.68	-3.57
Other Unusual Items	27.43	24.42	36.83	17.25	17.58
Pretax Income	936.29	745.97	596.37	395.13	221.55
Income Tax Expense	128.55	87.8	74.24	54.98	26.7
Earnings From Continuing Operations	807.74	658.17	522.13	340.16	194.85
Minority Interest in Earnings	12.9	14.98	11.79	17.86	13.07
Net Income	820.64	673.15	533.92	358.02	207.92
Net Income to Common	820.64	673.15	533.92	358.02	207.92
Net Income Growth	21.91%	26.08%	49.13%	72.19%	87.70%
Shares Outstanding (Basic)	141	140	140	140	137
Shares Outstanding (Diluted)	141	141	142	142	138
Shares Change (YoY)	0.05%	-0.27%	-0.16%	2.99%	31.45%
EPS (Basic)	5.82	4.80	3.82	2.56	1.52
EPS (Diluted)	5.80	4.76	3.77	2.52	1.51
EPS Growth	21.85%	26.41%	49.38%	67.20%	42.79%
Free Cash Flow	682.17	93.15	487.03	224.25	14.01
Free Cash Flow Per Share	4.82	0.66	3.44	1.58	0.10
Dividend Per Share	1.000	1.207	0.951	0.785	0.476
Dividend Growth	-17.14%	26.88%	21.20%	65.01%	100.00%
Gross Margin	72.62%	71.93%	70.54%	70.88%	68.74%
Operating Margin	34.37%	34.54%	31.81%	30.01%	21.20%
Profit Margin	31.76%	32.58%	32.36%	29.44%	25.09%
Free Cash Flow Margin	26.40%	4.51%	29.51%	18.44%	1.69%
EBITDA	988.48	790.98	580.9	405.69	203.49
EBITDA Margin	38.26%	38.29%	35.20%	33.36%	24.56%
D&A For EBITDA	100.47	77.38	56.04	40.7	27.81
EBIT	888.01	713.59	524.86	364.99	175.68
EBIT Margin	34.37%	34.54%	31.80%	30.01%	21.20%
Effective Tax Rate	13.73%	11.77%	12.45%	13.91%	12.05%
Revenue as Reported	2,584	2,066	1,650	1,216	828.69

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.